Review article · 2021 · Open access
PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
Frontiers in Pharmacology, 12, 692574 · Published 7 May 2021 · DOI 10.3389/fphar.2021.692574
In brief
“PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy” is a 2021 review article by Simin Qi and 5 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 324 citations as of 21 November 2026, which puts it in the top 2% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.
- Citations
- 324
- Most cited in
- 2022 (77)
- Field-weighted impact
- 5.30
- References
- 101
- Authors
- 6
Abstract
Proteolysis targeting chimeric (PROTAC) technology is an effective endogenous protein degradation tool developed in recent years that can ubiquitinate the target proteins through the ubiquitin-proteasome system (UPS) to achieve an effect on tumor growth. A number of literature studies on PROTAC technology have proved an insight into the feasibility of PROTAC technology to degrade target proteins. Additionally, the first oral PROTACs (ARV-110 and ARV-471) have shown encouraging results in clinical trials for prostate and breast cancer treatment, which inspires a greater enthusiasm for PROTAC research. Here we focus on the structures and mechanisms of PROTACs and describe several classes of effective PROTAC degraders based on E3 ligases.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Qi, S., Dong, J., Xu, Z., Cheng, X., Zhang, W., & Qin, J. (2021). PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy. Frontiers in Pharmacology, 12, 692574. https://doi.org/10.3389/fphar.2021.692574
MLA 9
Qi, Simin, et al. “PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy.” Frontiers in Pharmacology, vol. 12, 2021, p. 692574. https://doi.org/10.3389/fphar.2021.692574.
Chicago
Qi, Simin, Jinyun Dong, Zhiyuan Xu, Xiangdong Cheng, Weidong Zhang, and Jiang‐Jiang Qin. 2021. “PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy.” Frontiers in Pharmacology 12: 692574. https://doi.org/10.3389/fphar.2021.692574.
Harvard
Qi, S. et al. (2021) ‘PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy’, Frontiers in Pharmacology, 12, p. 692574. doi:10.3389/fphar.2021.692574.
IEEE
S. Qi, J. Dong, Z. Xu, X. Cheng, W. Zhang, and J. Qin, “PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy,” Frontiers in Pharmacology, vol. 12, p. 692574, 2021, doi: 10.3389/fphar.2021.692574.
BibTeX
@article{qi2021protac,
title = {{PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy}},
author = {Qi, Simin and Dong, Jinyun and Xu, Zhiyuan and Cheng, Xiangdong and Zhang, Weidong and Qin, Jiang‐Jiang},
journal = {Frontiers in Pharmacology},
year = {2021},
volume = {12},
pages = {692574},
doi = {10.3389/fphar.2021.692574},
url = {https://doi.org/10.3389/fphar.2021.692574}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2021 | 9 | |
| 2022 | 77 | |
| 2023 | 68 | |
| 2024 | 57 | |
| 2025 | 67 | |
| 2026 | 45 |
Its field-weighted citation impact is 5.30: it has been cited 5.30 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- PROTACs
- targeted protein degradation
- ubiquitin-proteasome system
- E3 ubiquitin ligase
- ARV-471
- prostate cancer
- breast cancer
- cancer therapy
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Qi, S., Dong, J., Xu, Z., Cheng, X., Zhang, W., & Qin, J. (2021). PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy. Frontiers in Pharmacology, 12, 692574. https://doi.org/10.3389/fphar.2021.692574
How many times has this paper been cited?
324 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.
Who wrote this paper?
Simin Qi, Jinyun Dong, Zhiyuan Xu, Xiangdong Cheng, Weidong Zhang, Jiang‐Jiang Qin.
What is the DOI of this paper?
10.3389/fphar.2021.692574, permanently at https://doi.org/10.3389/fphar.2021.692574. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.